Correlation Between Pfizer and Coroware

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Coroware at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Coroware into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Coroware, you can compare the effects of market volatilities on Pfizer and Coroware and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Coroware. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Coroware.

Diversification Opportunities for Pfizer and Coroware

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pfizer and Coroware is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Coroware in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coroware and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Coroware. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coroware has no effect on the direction of Pfizer i.e., Pfizer and Coroware go up and down completely randomly.

Pair Corralation between Pfizer and Coroware

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Coroware. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 201.68 times less risky than Coroware. The stock trades about -0.05 of its potential returns per unit of risk. The Coroware is currently generating about 0.31 of returns per unit of risk over similar time horizon. If you would invest  0.03  in Coroware on August 31, 2024 and sell it today you would lose (0.03) from holding Coroware or give up 100.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  Coroware

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The new stock price tumult, may contribute to shorter-term losses for the shareholders.
Coroware 

Risk-Adjusted Performance

31 of 100

 
Weak
 
Strong
Very Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Coroware are ranked lower than 31 (%) of all global equities and portfolios over the last 90 days. Despite fairly fragile basic indicators, Coroware demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and Coroware Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Coroware

The main advantage of trading using opposite Pfizer and Coroware positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Coroware can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coroware will offset losses from the drop in Coroware's long position.
The idea behind Pfizer Inc and Coroware pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Global Correlations
Find global opportunities by holding instruments from different markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal